Literature DB >> 17690700

Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules.

A Liso, D Colau, R Benmaamar, A De Groot, W Martin, R Benedetti, G Specchia, M P Martelli, P Coulie, B Falini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690700     DOI: 10.1038/sj.leu.2404887

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.

Authors:  Kateřina Kuželová; Barbora Brodská; Ota Fuchs; Marie Dobrovolná; Petr Soukup; Petr Cetkovský
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

2.  Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Authors:  Kateřina Kuželová; Barbora Brodská; Johannes Schetelig; Christoph Röllig; Zdeněk Ráčil; Juliane Stickel Walz; Grzegorz Helbig; Ota Fuchs; Milena Vraná; Pavla Pecherková; Cyril Šálek; Jiří Mayer
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

3.  Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.

Authors:  Rupa Narayan; Niclas Olsson; Lisa E Wagar; Bruno C Medeiros; Everett Meyer; Debra Czerwinski; Michael S Khodadoust; Lichao Zhang; Liora Schultz; Mark M Davis; Joshua E Elias; Ron Levy
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

4.  Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.

Authors:  Wei-Yu Lin; Sarah E Fordham; Eric Hungate; Nicola J Sunter; Claire Elstob; Yaobo Xu; Catherine Park; Anne Quante; Konstantin Strauch; Christian Gieger; Andrew Skol; Thahira Rahman; Lara Sucheston-Campbell; Junke Wang; Theresa Hahn; Alyssa I Clay-Gilmour; Gail L Jones; Helen J Marr; Graham H Jackson; Tobias Menne; Mathew Collin; Adam Ivey; Robert K Hills; Alan K Burnett; Nigel H Russell; Jude Fitzgibbon; Richard A Larson; Michelle M Le Beau; Wendy Stock; Olaf Heidenreich; Abrar Alharbi; David J Allsup; Richard S Houlston; Jean Norden; Anne M Dickinson; Elisabeth Douglas; Clare Lendrem; Ann K Daly; Louise Palm; Kim Piechocki; Sally Jeffries; Martin Bornhäuser; Christoph Röllig; Heidi Altmann; Leo Ruhnke; Desiree Kunadt; Lisa Wagenführ; Heather J Cordell; Rebecca Darlay; Mette K Andersen; Maria C Fontana; Giovanni Martinelli; Giovanni Marconi; Miguel A Sanz; José Cervera; Inés Gómez-Seguí; Thomas Cluzeau; Chimène Moreilhon; Sophie Raynaud; Heinz Sill; Maria Teresa Voso; Francesco Lo-Coco; Hervé Dombret; Meyling Cheok; Claude Preudhomme; Rosemary E Gale; David Linch; Julia Gaal-Wesinger; Andras Masszi; Daniel Nowak; Wolf-Karsten Hofmann; Amanda Gilkes; Kimmo Porkka; Jelena D Milosevic Feenstra; Robert Kralovics; David Grimwade; Manja Meggendorfer; Torsten Haferlach; Szilvia Krizsán; Csaba Bödör; Friedrich Stölzel; Kenan Onel; James M Allan
Journal:  Nat Commun       Date:  2021-10-29       Impact factor: 14.919

5.  Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.

Authors:  Francesca Ferraro; Christopher A Miller; Keegan A Christensen; Nichole M Helton; Margaret O'Laughlin; Catrina C Fronick; Robert S Fulton; Jessica Kohlschmidt; Ann-Kathrin Eisfeld; Clara D Bloomfield; Sai Mukund Ramakrishnan; Ryan B Day; Lukas D Wartman; Geoffrey L Uy; John S Welch; Matthew J Christopher; Sharon E Heath; Jack D Baty; Matthew J Schuelke; Jacqueline E Payton; David H Spencer; Michael P Rettig; Daniel C Link; Matthew J Walter; Peter Westervelt; John F DiPersio; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 11.205

Review 6.  Current status and future perspectives in targeted therapy of NPM1-mutated AML.

Authors:  Roberta Ranieri; Giulia Pianigiani; Sofia Sciabolacci; Vincenzo Maria Perriello; Andrea Marra; Valeria Cardinali; Sara Pierangeli; Francesca Milano; Ilaria Gionfriddo; Lorenzo Brunetti; Maria Paola Martelli; Brunangelo Falini
Journal:  Leukemia       Date:  2022-08-25       Impact factor: 12.883

Review 7.  The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy.

Authors:  Lourdes M Mendez; Ryan R Posey; Pier Paolo Pandolfi
Journal:  Front Oncol       Date:  2019-11-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.